Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125220022 | 12522002 | 2 | F | 201605 | 20160708 | 20160701 | 20160714 | EXP | US-UNITED THERAPEUTICS-UNT-2016-007490 | UNITED THERAPEUTICS | 31.31 | YR | F | Y | 86.17000 | KG | 20160714 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125220022 | 12522002 | 1 | PS | REMODULIN | TREPROSTINIL | 1 | Intravenous drip | 0.006 ?G/KG, CONTINUING | Y | 926617 | 21272 | .006 | UG/KG | INJECTION | |||||
| 125220022 | 12522002 | 2 | SS | REMODULIN | TREPROSTINIL | 1 | Intravenous drip | 0.012 ?G/KG, CONTINUING | Y | 926617 | 21272 | .012 | UG/KG | INJECTION | |||||
| 125220022 | 12522002 | 3 | SS | REMODULIN | TREPROSTINIL | 1 | Intravenous drip | 0.018 ?G/KG, CONTINUING | Y | 926617 | 21272 | .018 | UG/KG | INJECTION | |||||
| 125220022 | 12522002 | 4 | C | K-TAB | POTASSIUM CHLORIDE | 1 | Oral | 10 ?G, QD | 0 | 10 | UG | QD | |||||||
| 125220022 | 12522002 | 5 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 300-30 MG AS MUCH AS SUFFICIENT (QS) WHEN REQUIRED (PRN) | 0 | ||||||||||
| 125220022 | 12522002 | 6 | C | REVATIO | SILDENAFIL CITRATE | 1 | Oral | 20 MG (THREE TABLETS), TID | 0 | 20 | MG | TID | |||||||
| 125220022 | 12522002 | 7 | C | COUMADIN | WARFARIN SODIUM | 1 | Oral | 5 MG, PRN | 0 | 5 | MG | ||||||||
| 125220022 | 12522002 | 8 | C | CARDIZEM | DILTIAZEM HYDROCHLORIDE | 1 | Oral | 30 MG, QD, PRN | 0 | 30 | MG | QD | |||||||
| 125220022 | 12522002 | 9 | C | PEPCID /00305201/ | ALUMINUM HYDROXIDEMAGNESIUM CARBONATE | 1 | Unknown | 40 MG, BID | 0 | 40 | MG | BID | |||||||
| 125220022 | 12522002 | 10 | C | MIRENA | LEVONORGESTREL | 1 | Unknown | 20 ?G, QD FOR 10 DAYS | 0 | 20 | UG | QD | |||||||
| 125220022 | 12522002 | 11 | C | LETAIRIS | AMBRISENTAN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125220022 | 12522002 | 1 | Pulmonary hypertension |
| 125220022 | 12522002 | 4 | Product used for unknown indication |
| 125220022 | 12522002 | 5 | Headache |
| 125220022 | 12522002 | 6 | Product used for unknown indication |
| 125220022 | 12522002 | 7 | Product used for unknown indication |
| 125220022 | 12522002 | 8 | Palpitations |
| 125220022 | 12522002 | 9 | Product used for unknown indication |
| 125220022 | 12522002 | 10 | Product used for unknown indication |
| 125220022 | 12522002 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125220022 | 12522002 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125220022 | 12522002 | Chest pain | |
| 125220022 | 12522002 | Dyspnoea exertional | |
| 125220022 | 12522002 | Fatigue | |
| 125220022 | 12522002 | Gastrooesophageal reflux disease | |
| 125220022 | 12522002 | Limb discomfort | |
| 125220022 | 12522002 | Nausea | |
| 125220022 | 12522002 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125220022 | 12522002 | 1 | 20160429 | 0 | ||
| 125220022 | 12522002 | 3 | 20160614 | 0 |